Clinical trial
Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction
NCT02098629 is registered in ClinicalTrials.gov with Shantou University Medical College as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction
- Lead sponsor
- Shantou University Medical College
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- December 31, 2024
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.